Compare DexCom, Inc. (DXCM) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Prologis Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Prologis Inc trades at $139.28 (market cap $132.57B). The key difference: Prologis Inc is far larger — about 3.9× DexCom, Inc.'s market cap, and Prologis Inc pays a 3.07% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | PLD | |
|---|---|---|
Market Cap | $33.79B | $132.57B |
Sector | Health | Real Estate |
52-Week High | $89.53 | $149.96 |
52-Week Low | $54.84 | $104.81 |
Enterprise Value | $33.24B | $167.31B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
